Review
Published on 03 Apr 2025
Fibroblast heterogeneity and its role in generating protective immunity in the secondary lymphoid organs
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1519789
Type at least 3 characters
43,046 articles
Case Report
Published on 03 Apr 2025
Case Report: Decentralized trial of tolerability-adapted exercise therapy after severe Covid-19
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1529385
- 124 views
Original Research
Published on 03 Apr 2025
Cadonilimab plus chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer: a cost-effectiveness analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1562875
- 161 views
Editorial
Published on 03 Apr 2025
Editorial: Crosstalk in ferroptosis, immunity & inflammation
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1587075
Perspective
Published on 03 Apr 2025
Monitoring immunological COVID-19 vaccine clinical testing across the CEPI Centralized Laboratory Network
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1569251
Original Research
Published on 03 Apr 2025
mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1505871
- 241 views
Review
Accepted on 02 Apr 2025
Regulation of the Tuft Cell-ILC2 Circuit in Intestinal Mucosal
in Mucosal Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1568062
Review
Accepted on 02 Apr 2025
Circular RNAs in inflammatory bowel disease: A review of mechanisms, biomarkers and therapeutic potential
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1540768
Mini Review
Accepted on 02 Apr 2025
Dendritic Cells in Multiple Myeloma: From Immune Evasion to Therapeutic Potential
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1575509
Original Research
Accepted on 02 Apr 2025
The CD38+ HLA-DR+ T Cells with Activation and Exhaustion Characteristics as Predictors of Severity and Mortality in COVID-19 patients
in Immunological Tolerance and Regulation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1577803
Review
Accepted on 02 Apr 2025
Role and Mechanisms of Exercise Therapy in Enhancing Drug Treatment for Glioma: A Review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1576283
Review
Accepted on 02 Apr 2025
Long non-coding RNAs as Key Modulators of the Immune Microenvironment in Hepatocellular Carcinoma: Implications for Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1523190
Review
Accepted on 02 Apr 2025
Tissue-Resident Immune Cells in Cervical Cancer: Emerging Roles and Therapeutic Implications
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1541950
Original Research
Accepted on 02 Apr 2025
Ubiquitination and ALL: Identifying FBXO8 as a Prognostic Biomarker and Therapeutic Target
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1554231
Case Report
Accepted on 02 Apr 2025
SMARCA4-deficient NSCLC treated with first-line Tislelizumab and Fruquintinib achieved remarkable tumor regression: Case Report and Literature review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1521828
Methods
Accepted on 02 Apr 2025
SAPrIm 2.0: A semi-automated protocol for midthroughput soluble HLA immunopeptidomics
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1546629